New coronavirus neutralizing antibody detection kit based on trimer S protein RBD-ACE2 binding competition
A technology for RBD-ACE2 and antibody detection, which is applied in measuring devices, color/spectral characteristic measurement, and material analysis by observing the impact on chemical indicators, etc., can solve the tedious and time-consuming problem of inability to distinguish total binding antibodies and neutralizing antibodies and other problems, to achieve the effect of less interference factors, increase the detection rate of new crowns, and simple operation
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Example 1 A novel coronavirus neutralizing antibody detection kit based on trimeric S protein RBD-ACE2 binding competition
[0046] 1. Composition
[0047] 1. The solid phase carrier (96-well plate or 48-well plate) coated with the S protein RBD (GenScript Z03483) (400ng / well) of the trimeric structure, wherein the SARS-CoV-2 RBD has a His tag. The His antibody is coated on the solid phase carrier, and then the RBD is coated on the solid phase carrier by the His antibody;
[0048] 2. Biotin-labeled ACE2 protein
[0049] 3. Positive control substance: the serum of a person with high expression of neutralizing antibodies after injection of the new crown vaccine;
[0050] 4. Negative control substance: a mixture of sera from 20 healthy examinees over the age of 18 who have not been infected with the new coronavirus and other coronaviruses, and who have not been vaccinated against the new coronavirus;
[0051] 5. Enzyme-labeled secondary antibody: HRP-streptavidin;
[005...
Embodiment 2
[0065] The detection of embodiment 2 vaccine injector's blood sample
[0066] 1. Experimental method
[0067] 1. In order to test the detection effect of the kit in vaccine injectors, use the kit in Example 1 to detect clinical samples. In this example, 8 vaccinators were included, and 18 healthy subjects were also included as controls.
[0068] 2. Experimental results
[0069] The test results are shown in Table 1. The inhibition rates of the 8 vaccinators were all greater than 30%. This kit can detect neutralizing antibodies in serum.
[0070] Table 1:
[0071]
[0072]
Embodiment 3
[0073] Example 3 Detection of Blood Samples from New Coronary Rehabilitation Patients
[0074] 1. Experimental method
[0075] 1. In order to test the detection effect of this kit in patients who have recovered from COVID-19, the kit in Example 1 is used to detect clinical samples. In this example, 12 recovered patients from the new crown were included.
[0076] 2. Experimental results
[0077] The test results are shown in Table 2, 12 recovered patients from the new crown. The inhibition rates are all greater than 30%. This kit can detect neutralizing antibodies in serum.
[0078] Table 2:
[0079]
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


